Latent cytomegalovirus (CMV) infection does not detrimentally alter T cell responses in the healthy old, but increased latent CMV carriage is related to expanded CMV-specific T cells

Frontiers in Immunology

Volumn 8, Issue JUN, 2017, Pages

  Jackson, Sarah E ^a   Sedikides, George X ^a   Okecha, Georgina ^a   Poole, Emma L ^a   Sinclair, John H ^a   Wills, Mark R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

CIL 10+CD4+ T cells; Human cytomegalovirus; Human cytomegalovirus specific T cells; IFN production; Immunology of aging; Latent viral load; Viral latency

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY;

ANTIVIRAL THERAPY; ARTICLE; BLOOD; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CYTOMEGALOVIRUS; GENE FREQUENCY; HUMAN CYTOMEGALOVIRUS; IMMUNOMODULATION; LATENT VIRUS INFECTION; MONOCYTE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; T LYMPHOCYTE; VIREMIA; VIRUS GENE; VIRUS LOAD; VIRUS REACTIVATION;

EID: 85021206702     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.00733     Document Type: Article

References (79)

1. McElhaney JE, Effros RB. Immunosenescence: what does it mean to health outcomes in older adults? Curr Opin Immunol (2009) 21(4):418-24. doi:10.1016/j.coi.2009.05.023
2. Denkinger MD, Leins H, Schirmbeck R, Florian MC, Geiger H. HSC aging and senescent immune remodeling. Trends Immunol (2015) 36(12):815-24. doi:10.1016/j.it.2015.10.008
3. Kline KA, Bowdish DM. Infection in an aging population. Curr Opin Microbiol (2016) 29:63-7. doi:10.1016/j.mib.2015.11.003
4. Sinclair J, Sissons P. Latency and reactivation of human cytomegalovirus. J Gen Virol (2006) 87(Pt 7):1763-79. doi:10.1099/vir.0.81891-0
5. Wills MR, Poole E, Lau B, Krishna B, Sinclair JH. The immunology of human cytomegalovirus latency: could latent infection be cleared by novel immunotherapeutic strategies? Cell Mol Immunol (2015) 12(2):128-38. doi:10.1038/cmi.2014.75
6. Crough T, Khanna R. Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev (2009) 22(1):76-98. doi:10.1128/CMR.00034-08
7. Jackson SE, Mason GM, Wills MR. Human cytomegalovirus immunity and immune evasion. Virus Res (2011) 157(2):151-60. doi:10.1016/j.virusres.2010.10.031
8. Olsson J, Wikby A, Johansson B, Löfgren S, Nilsson B-O, Ferguson FG. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev (2001) 121(1-3):187-201. doi:10.1016/s0047-6374(00)00210-4
9. Wikby A, Johansson B, Olsson J, Lofgren S, Nilsson BO, Ferguson F. Expansions of peripheral blood CD8 T-lymphocyte subpopulations and an association with cytomegalovirus seropositivity in the elderly: the Swedish NONA immune study. Exp Gerontol (2002) 37(2-3):445-53. doi:10.1016/S0531-5565(01)00212-1
10. Trzonkowski P, Mysliwska J, Szmit E, Wieckiewicz J, Lukaszuk K, Brydak LB, et al. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination-an impact of immunosenescence. Vaccine (2003) 21(25-26):3826-36. doi:10.1016/S0264-410x(03)00309-8
11. Ouyang Q, Wagner WM, Zheng W, Wikby A, Remarque EJ, Pawelec G. Dysfunctional CMV-specific CD8(+) T cells accumulate in the elderly. Exp Gerontol (2004) 39(4):607-13. doi:10.1016/j.exger.2003.11.016
12. Hadrup SR, Strindhall J, Kollgaard T, Seremet T, Johansson B, Pawelec G, et al. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J Immunol (2006) 176(4):2645-53. doi:10.4049/jimmunol.176.4.2645
13. Strindhall J, Skog M, Ernerudh J, Bengner M, Lofgren S, Matussek A, et al. The inverted CD4/CD8 ratio and associated parameters in 66-year-old individuals: the Swedish HEXA immune study. Age (Dordr) (2013) 35(3):985-91. doi:10.1007/s11357-012-9400-3
14. Simanek AM, Dowd JB, Pawelec G, Melzer D, Dutta A, Aiello AE. Seropositivity to cytomegalovirus, inflammation, all-cause and cardiovascular disease-related mortality in the United States. PLoS One (2011) 6(2):e16103. doi:10.1371/journal.pone.0016103
15. Gkrania-Klotsas E, Langenberg C, Sharp SJ, Luben R, Khaw KT, Wareham NJ. Higher immunoglobulin G antibody levels against cytomegalovirus are associated with incident ischemic heart disease in the population-based EPIC-Norfolk cohort. J Infect Dis (2012) 206(12):1897-903. doi:10.1093/infdis/jis620
16. Olson NC, Doyle MF, Jenny NS, Huber SA, Psaty BM, Kronmal RA, et al. Decreased naive and increased memory CD4(+) T cells are associated with subclinical atherosclerosis: the multi-ethnic study of atherosclerosis. PLoS One (2013) 8(8):e71498. doi:10.1371/journal.pone.0071498
17. Savva GM, Pachnio A, Kaul B, Morgan K, Huppert FA, Brayne C, et al. Cytomegalovirus infection is associated with increased mortality in the older population. Aging Cell (2013) 12(3):381-7. doi:10.1111/acel.12059
18. Spyridopoulos I, Martin-Ruiz C, Hilkens C, Yadegarfar ME, Isaacs J, Jagger C, et al. CMV seropositivity and T-cell senescence predict increased cardiovascular mortality in octogenarians: results from the Newcastle 85+ study. Aging Cell (2016) 15(2):389-92. doi:10.1111/acel.12430
19. Lelic A, Verschoor CP, Ventresca M, Parsons R, Evelegh C, Bowdish D, et al. The polyfunctionality of human memory CD8+ T cells elicited by acute and chronic virus infections is not influenced by age. PLoS Pathog (2012) 8(12):e1003076. doi:10.1371/journal.ppat.1003076
20. Schulz AR, Malzer JN, Domingo C, Jurchott K, Grutzkau A, Babel N, et al. Low thymic activity and dendritic cell numbers are associated with the immune response to primary viral infection in elderly humans. J Immunol (2015) 195(10):4699-711. doi:10.4049/jimmunol.1500598
21. Furman D, Jojic V, Sharma S, Shen-Orr SS, Angel CJ, Onengut-Gumuscu S, et al. Cytomegalovirus infection enhances the immune response to influenza. Sci Transl Med (2015) 7(281):281ra243. doi:10.1126/scitranslmed.aaa2293
22. Collerton J, Martin-Ruiz C, Davies K, Hilkens CM, Isaacs J, Kolenda C, et al. Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: cross-sectional findings from the Newcastle 85+ study. Mech Ageing Dev (2012) 133(6):456-66. doi:10.1016/j.mad.2012.05.005
23. Bartlett DB, Firth CM, Phillips AC, Moss P, Baylis D, Syddall H, et al. The age-related increase in low-grade systemic inflammation (inflammaging) is not driven by cytomegalovirus infection. Aging Cell (2012) 11(5):912-5. doi:10.1111/j.1474-9726.2012.00849.x
24. Weltevrede M, Eilers R, de Melker HE, van Baarle D. Cytomegalovirus persistence and T-cell immunosenescence in people aged fifty and older: a systematic review. Exp Gerontol (2016) 77:87-95. doi:10.1016/j.exger.2016.02.005
25. Harari A, Vallelian F, Pantaleo G. Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load. Eur J Immunol (2004) 34(12):3525-33. doi:10.1002/eji.200425324
26. Henson SM, Franzese O, Macaulay R, Libri V, Azevedo RI, Kiani-Alikhan S, et al. KLRG1 signaling induces defective Akt (ser473) phosphorylation and proliferative dysfunction of highly differentiated CD8+ T cells. Blood (2009) 113(26):6619-28. doi:10.1182/blood-2009-01-199588
27. Vescovini R, Biasini C, Telera AR, Basaglia M, Stella A, Magalini F, et al. Intense antiextracellular adaptive immune response to human cytomegalovirus in very old subjects with impaired health and cognitive and functional status. J Immunol (2010) 184(6):3242-9. doi:10.4049/jimmunol.0902890
28. Derhovanessian E, Maier AB, Hahnel K, McElhaney JE, Slagboom EP, Pawelec G. Latent infection with cytomegalovirus is associated with poor memory CD4 responses to influenza A core proteins in the elderly. J Immunol (2014) 193(7):3624-31. doi:10.4049/jimmunol.1303361
29. Broadley I, Pera A, Morrow G, Davies KA, Kern F. Expansions of cytotoxic CD4+CD28-T cells drive excess cardiovascular mortality in rheumatoid arthritis and other chronic inflammatory conditions and are triggered by CMV infection. Front Immunol (2017) 8:195. doi:10.3389/fimmu.2017.00195
30. Miles DJ, van der Sande M, Jeffries D, Kaye S, Ismaili J, Ojuola O, et al. Cytomegalovirus infection in Gambian infants leads to profound CD8 T-cell differentiation. J Virol (2007) 81(11):5766-76. doi:10.1128/JVI.00052-07
31. Waller EC, McKinney N, Hicks R, Carmichael AJ, Sissons JG, Wills MR. Differential costimulation through CD137 (4-1BB) restores proliferation of human virus-specific "effector memory" (CD28(-) CD45RA(HI)) CD8(+) T cells. Blood (2007) 110(13):4360-6. doi:10.1182/blood-2007-07-104604
32. Riddell NE, Griffiths SJ, Rivino L, King DC, Teo GH, Henson SM, et al. Multifunctional cytomegalovirus (CMV)-specific CD8(+) T cells are not restricted by telomere-related senescence in young or old adults. Immunology (2015) 144(4):549-60. doi:10.1111/imm.12409
33. Casazza JP, Betts MR, Price DA, Precopio ML, Ruff LE, Brenchley JM, et al. Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation. J Exp Med (2006) 203(13):2865-77. doi:10.1084/jem.20052246
34. Lachmann R, Bajwa M, Vita S, Smith H, Cheek E, Akbar A, et al. Polyfunctional T cells accumulate in large human cytomegalovirus-specific T cell responses. J Virol (2012) 86(2):1001-9. doi:10.1128/JVI.00873-11
35. Riou C, Treurnicht F, Abrahams MR, Mlisana K, Liu MK, Goonetilleke N, et al. Increased memory differentiation is associated with decreased polyfunctionality for HIV but not for cytomegalovirus-specific CD8+ T cells. J Immunol (2012) 189(8):3838-47. doi:10.4049/jimmunol.1201488
36. Stowe RP, Kozlova EV, Yetman DL, Walling DM, Goodwin JS, Glaser R. Chronic herpesvirus reactivation occurs in aging. Exp Gerontol (2007) 42(6):563-70. doi:10.1016/j.exger.2007.01.005
37. Furui Y, Satake M, Hoshi Y, Uchida S, Suzuki K, Tadokoro K. Cytomegalovirus (CMV) seroprevalence in Japanese blood donors and high detection frequency of CMV DNA in elderly donors. Transfusion (2013) 53(10):2190-7. doi:10.1111/trf.12390
38. Goodrum F, Reeves M, Sinclair J, High K, Shenk T. Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro. Blood (2007) 110(3):937-45. doi:10.1182/blood-2007-01-070078
39. Bego M, Maciejewski J, Khaiboullina S, Pari G, St Jeor S. Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus. J Virol (2005) 79(17):11022-34. doi:10.1128/JVI.79.17.11022-11034.2005
40. Reeves MB, Sinclair JH. Analysis of latent viral gene expression in natural and experimental latency models of human cytomegalovirus and its correlation with histone modifications at a latent promoter. J Gen Virol (2010) 91(Pt 3):599-604. doi:10.1099/vir.0.015602-0
41. Beisser PS, Laurent L, Virelizier JL, Michelson S. Human cytomegalovirus chemokine receptor gene US28 is transcribed in latently infected THP-1 monocytes. J Virol (2001) 75(13):5949-57. doi:10.1128/JVI.75.13.5949-5957.2001
42. Jenkins C, Abendroth A, Slobedman B. A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. J Virol (2004) 78(3):1440-7. doi:10.1128/Jvi.78.3.1440-1447.2004
43. Poole E, Walther A, Raven K, Benedict CA, Mason GM, Sinclair J. The myeloid transcription factor GATA-2 regulates the viral UL144 gene during human cytomegalovirus latency in an isolate-specific manner. J Virol (2013) 87(8):4261-71. doi:10.1128/JVI.03497-12
44. Mason GM, Poole E, Sissons JG, Wills MR, Sinclair JH. Human cytomegalovirus latency alters the cellular secretome, inducing cluster of differentiation (CD)4+ T-cell migration and suppression of effector function. Proc Natl Acad Sci U S A (2012) 109(36):14538-43. doi:10.1073/pnas.1204836109
45. Tovar-Salazar A, Patterson-Bartlett J, Jesser R, Weinberg A. Regulatory function of cytomegalovirus-specific CD4+CD27-CD28-T cells. Virology (2010) 398(2):158-67. doi:10.1016/j.virol.2009.11.038
46. Schwele S, Fischer AM, Brestrich G, Wlodarski MW, Wagner L, Schmueck M, et al. Cytomegalovirus-specific regulatory and effector T cells share TCR clonality-possible relation to repetitive CMV infections. Am J Transplant (2012) 12(3):669-81. doi:10.1111/j.1600-6143.2011.03842.x
47. Terrazzini N, Bajwa M, Vita S, Cheek E, Thomas D, Seddiki N, et al. A novel cytomegalovirus-induced regulatory-type T-cell subset increases in size during older life and links virus-specific immunity to vascular pathology. J Infect Dis (2014) 209(9):1382-92. doi:10.1093/infdis/jit576
48. Derhovanessian E, Chen S, Maier AB, Hahnel K, de Craen AJ, Roelofs H, et al. CCR4+ regulatory T cells accumulate in the very elderly and correlate with superior 8-year survival. J Gerontol A Biol Sci Med Sci (2015) 70(8):917-23. doi:10.1093/gerona/glu128
49. Clement M, Marsden M, Stacey MA, Abdul-Karim J, Gimeno Brias S, Costa Bento D, et al. Cytomegalovirus-specific IL-10-producing CD4+ T cells are governed by type-I IFN-induced IL-27 and promote virus persistence. PLoS Pathog (2016) 12(12):e1006050. doi:10.1371/journal.ppat.1006050
50. Jost NH, Abel S, Hutzler M, Sparwasser T, Zimmermann A, Roers A, et al. Regulatory T cells and T-cell-derived IL-10 interfere with effective anti-cytomegalovirus immune response. Immunol Cell Biol (2014) 92(10):860-71. doi:10.1038/icb.2014.62
51. Gregg R, Smith CM, Clark FJ, Dunnion D, Khan N, Chakraverty R, et al. The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age. Clin Exp Immunol (2005) 140(3):540-6. doi:10.1111/j.1365-2249.2005.02798.x
52. Chidrawar S, Khan N, Wei W, McLarnon A, Smith N, Nayak L, et al. Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals. Clin Exp Immunol (2009) 155(3):423-32. doi:10.1111/j.1365-2249.2008.03785.x
53. Mason GM, Jackson SE, Okecha G, Poole E, Sissons JG, Sinclair J, et al. Human cytomegalovirus latency-associated proteins elicit immune-suppressive IL-10 producing CD4(+) T cells. PLoS Pathog (2013) 9(10):e1003635. doi:10.1371/journal.ppat.1003635
54. Parry HM, Zuo J, Frumento G, Mirajkar N, Inman C, Edwards E, et al. Cytomegalovirus viral load within blood increases markedly in healthy people over the age of 70 years. Immun Ageing (2016) 13(1):1. doi:10.1186/s12979-015-0056-6
55. Hensley-McBain T, Heit A, De Rosa SC, McElrath MJ, Andersen-Nissen E. Optimization of a whole blood phenotyping assay for enumeration of peripheral blood leukocyte populations in multicenter clinical trials. J Immunol Methods (2014) 411:23-36. doi:10.1016/j.jim.2014.06.002
56. Sylwester AW, Mitchell BL, Edgar JB, Taormina C, Pelte C, Ruchti F, et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med (2005) 202(5):673-85. doi:10.1084/jem.20050882
57. Jackson SE, Mason GM, Okecha G, Sissons JG, Wills MR. Diverse specificities, phenotypes, and antiviral activities of cytomegalovirus-specific CD8+ T cells. J Virol (2014) 88(18):10894-908. doi:10.1128/JVI.01477-14
58. Mattes FM, Hainsworth EG, Hassan-Walker AF, Burroughs AK, Sweny P, Griffiths PD, et al. Kinetics of cytomegalovirus load decrease in solid-organ transplant recipients after preemptive therapy with valganciclovir. J Infect Dis (2005) 191(1):89-92. doi:10.1086/425905
59. Fox JC, Kidd IM, Griffiths PD, Sweny P, Emery VC. Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: correlation with disease. J Gen Virol (1995) 76(Pt 2):309-19. doi:10.1099/0022-1317-76-2-309
60. Fryer JF, Heath AB, Anderson R, Minor PD. Collaborative study to evaluate the proposed 1st WHO international standard for human cytomegalovirus (HCMV) for nucleic acid amplification (NAT)-based assays. WHO/BS/10.2138-Expert Committee on Biological Standardization. Geneva: World Health Organization (2010)
61. Roback JD, Hillyer CD, Drew WL, Laycock ME, Luka J, Mocarski ES, et al. Multicenter evaluation of PCR methods for detecting CMV DNA in blood donors. Transfusion (2001) 41(10):1249-57. doi:10.1046/j.1537-2995.2001.41101249.x
62. Hardy MY, Vari F, Rossetti T, Hart DN, Prue RL. A flow cytometry based assay for the enumeration of regulatory T cells in whole blood. J Immunol Methods (2013) 390(1-2):121-6. doi:10.1016/j.jim.2012.07.004
63. Jackson SE, Sedikides GX, Mason GM, Okecha G, Wills MR. Human cytomegalovirus (HCMV)-specific CD4+ T cells are polyfunctional and can respond to HCMV-infected dendritic cells in vitro. J Virol (2017) 91(6):16. doi:10.1128/JVI.02128-16
64. Reeves MB, MacAry PA, Lehner PJ, Sissons JG, Sinclair JH. Latency, chromatin remodeling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci U S A (2005) 102(11):4140-5. doi:10.1073/pnas.0408994102
65. Reeves MB, Sinclair JH. Circulating dendritic cells isolated from healthy seropositive donors are sites of human cytomegalovirus reactivation in vivo. J Virol (2013) 87(19):10660-7. doi:10.1128/JVI.01539-13
66. Lynch HE, Goldberg GL, Chidgey A, Van den Brink MR, Boyd R, Sempowski GD. Thymic involution and immune reconstitution. Trends Immunol (2009) 30(7):366-73. doi:10.1016/j.it.2009.04.003
67. Wertheimer AM, Bennett MS, Park B, Uhrlaub JL, Martinez C, Pulko V, et al. Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T cell subsets in humans. J Immunol (2014) 192(5):2143-55. doi:10.4049/jimmunol.1301721
68. McVoy MA, Adler SP. Immunologic evidence for frequent age-related cytomegalovirus reactivation in seropositive immunocompetent individuals. J Infect Dis (1989) 160(1):1-10. doi:10.1093/infdis/160.1.1
69. Alonso Arias R, Moro-Garcia MA, Echeverria A, Solano-Jaurrieta JJ, Suarez-Garcia FM, Lopez-Larrea C. Intensity of the humoral response to cytomegalovirus is associated with the phenotypic and functional status of the immune system. J Virol (2013) 87(8):4486-95. doi:10.1128/JVI.02425-12
70. Gamadia LE, Remmerswaal EB, Weel JF, Bemelman F, van Lier RA, Ten Berge IJ. Primary immune responses to human CMV: a critical role for IFN-gamma-producing CD4+ T cells in protection against CMV disease. Blood (2003) 101(7):2686-92. doi:10.1182/blood-2002-08-2502
71. Day EK, Carmichael AJ, Ten Berge IJM, Waller ECP, Sissons JGP, Wills MR. Rapid CD8(+) T cell repertoire focusing and selection of high-affinity clones into memory following primary infection with a persistent human virus: human cytomegalovirus. J Immunol (2007) 179(5):3203-13. doi:10.4049/jimmunol.179.5.3203
72. Lilleri D, Fornara C, Revello MG, Gerna G. Human cytomegalovirus-specific memory CD8+ and CD4+ T cell differentiation after primary infection. J Infect Dis (2008) 198(4):536-43. doi:10.1086/590118
73. Colonna-Romano G, Akbar AN, Aquino A, Bulati M, Candore G, Lio D, et al. Impact of CMV and EBV seropositivity on CD8 T lymphocytes in an old population from West-Sicily. Exp Gerontol (2007) 42(10):995-1002. doi:10.1016/j.exger.2007.05.006
74. Adriaensen W, Derhovanessian E, Vaes B, Van Pottelbergh G, Degryse JM, Pawelec G, et al. CD4:8 ratio >5 is associated with a dominant naive T-cell phenotype and impaired physical functioning in CMV-seropositive very elderly people: results from the BELFRAIL study. J Gerontol A Biol Sci Med Sci (2015) 70(2):143-54. doi:10.1093/gerona/glu018
75. Gandhi MK, Khanna R. Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. Lancet Infect Dis (2004) 4(12):725-38. doi:10.1016/S1473-3099(04)01202-2
76. Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol (2010) 20(4):202-13. doi:10.1002/rmv.655
77. Fletcher JM, Vukmanovic-Stejic M, Dunne PJ, Birch KE, Cook JE, Jackson SE, et al. Cytomegalovirus-specific CD4+ T cells in healthy carriers are continuously driven to replicative exhaustion. J Immunol (2005) 175(12):8218-25. doi:10.4049/jimmunol.175.12.8218
78. Vescovini R, Telera A, Fagnoni FF, Biasini C, Medici MC, Valcavi P, et al. Different contribution of EBV and CMV infections in very long-term carriers to age-related alterations of CD8(+) T cells. Exp Gerontol (2004) 39(8):1233-43. doi:10.1016/j.exger.2004.04.004
79. Haeseker MB, Pijpers E, Dukers-Muijrers NH, Nelemans P, Hoebe CJ, Bruggeman CA, et al. Association of cytomegalovirus and other pathogens with frailty and diabetes mellitus, but not with cardiovascular disease and mortality in psycho-geriatric patients; a prospective cohort study. Immun Ageing (2013) 10(1):30. doi:10.1186/1742-4933-10-30